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Bio-Analyses of Antimicrobial Biomaterials for Wound Dressings –
A Step Forward to Prevent Microbial Infection Diseases
Introduction: The aim of this study is the bio-evaluation of antimicrobial
biomaterials intended for wound dressings. As a wound dressing will be in
direct contact with the wound and therefore the skin cells, it should not only
be antibacterial to prevent infection at wound site but also be non-toxic to the
surrounding tissue. For this purpose, testing of the newly developed
biomaterials will be performed using in vitro assays based on 2D cell culture
(according to ISO 10993-5) & 3D cell culture systems as well as testing against
microbial biofilm formation.
Therefore the first part of my PhD thesis is focused on the
establishment of a suitable 3D skin model and, even more importantly, on the
development of cyto-compatibility assay protocols suitable for the testing of
material samples in this 3D system. In this study, we established a dermal
layer 3D model using L929 fibroblasts. We used this model for trials and
optimization of different methods of cytocompatibility analysis for example,
Live/Dead staining as well as quantitative assays to measure the amount of
viable and dead cells.
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Scheme of the construction of 3D skin model:
A collagen I gel (mimicking the extracellular
matrix) is embedded with human dermal
fibroblasts. After dermal fibroblasts contract
and remodel the collagen matrix, keratinocytes
are then seeded onto it. Tissues are then raised
to an air-liquid interface to initiate skin-
analogue tissue formation.
Effect of Repeated Exposure of CellTiter Reagent on Cells in 3DCell Viability and Cell Death of 3D Fibroblasts
Schools/Workshops/Industrial trainings/Courses/Publications:
-HYMEDPOLY WINTER SCHOOL 1 and workshop: 8th–10th February 2016, “Biodegradable polymers synthesis and functionalisation” Politechnico di Torino,Turin, Italy
-HYMEDPOLY Meeting and Workshop: 19th—20th July, 2016, “Biomaterials and cells interaction – new concepts of drug-free antibacterial therapies, University of Westminster, London, UK
-Workshop of the project Smart Injectable Drug-Delivery systems for Parkinson’s and Alzheimer’s Disease Treatment (PAD-INJ): 19th -20th November, 2015, “Engineered Biomaterials and Biomedical
Devices in the Regenerative Medicine of the Nervous System”, Doctoral School of Politecnico di Torino, Turin, Italy (Prof. Valeria Chiono and Prof. Maria Grazia Spillantini)
-BioPmed Seminar: 26th January 2016, “Biological evaluation of Medical Device: ISO 10993” , Bioindustry Park, Ivrea (Vicent Legay)
-Course: 11-13th November 2015, “Advancement in the knowledge and the treatment of neurodegenerative diseases” ,Doctoral School of Politecnico di Torino, Turin, Italy, (Prof. Maria Grazia Spillantini)
-Course: 23rd November 2015 , Enterpreneurship, Doctoral School of Politecnico di Torino, Turin, Italy, (Professor Erasmo Carrera and Dr. Marco Petrolo)
-Anticipated publication of the review article: “Drug-free antibacterial polymers for biomedical applications” , Journal: Biomedical Science and Engineering Page Press, (in progress)
PhD Day- PhD Cycle 31- 4th October, 2016-Politechnico di Torino, Italy
Both assays (CellTiter-Blue and CytoTox-ONE; www.promega.com) are 
adaptable to 3D system. Cells were viable for at least 20 days in matrix 
which is a prerequisite for such experiments.
Repeated exposure of cells to reagent for up to 18 days has no lasting toxic
effect. Therefore this assay can be used as a method to monitor cell viability
over an extended time frame.
Cells grown on conventional 2D surface have flattened
morphology, while the cells in the 3D matrix show filopodia (thin
cell membrane protrusions), and this morphology resembles the
in vivo situation.
This evidence shows that Live/Dead staining is also applicable in
3D skin model, indicating that cells can directly be observed to
assess morphological changes and sudden cell death as a result
of interaction with biomaterials.
H & E stained dermal layer showing fibroblasts 
with dendritic extensions in the matrix
Future Activity Plan: The knowledge deriving from this 3D model will be used to develop a human primary cell based in-vitro model (with
human dermal fibroblasts and epidermal keratinocytes) able to mimic human skin. Then the development and optimization of bio-assays in this
system will be performed to evaluate the cell compatibility of biomaterials.
Biofilm development and anti bacterial testing will be performed to evaluate the antibacterial properties. Work will start after meeting at the
Department for Medical Microbiology RUB (also National Reference Center for gram-negative bacteria) on the 19th of October.
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Cell Viability (cells never exposed to cellTiter reagent before)
Cell Viability (cells repeatedly exposed to cellTiter reagent for several days)
Cyto Toxicity (cells never exposed to cellTiter reagent before)
Cyto Toxicity (cells repeatedly exposed to cellTiter reagent for several days)
Development and Optimization of Quantitative Cytocompatibility Assays in 3D
3D skin model Development
Visualization of Cells in 3D
